BRIEF published on 03/19/2025 at 17:50, 1 year ago Résultats annuels 2024 d'Ateme : recul du chiffre d'affaires mais perspectives encourageantes Chiffre D'affaires EBITDA Revenus Récurrents Charges Opérationnelles Perspectives 2025
BRIEF published on 03/19/2025 at 17:50, 1 year ago Ateme's 2024 annual results: decline in turnover but encouraging outlook EBITDA Recurring Revenue Turnover Operating Expenses Outlook 2025
PRESS RELEASE published on 03/19/2025 at 17:50, 1 year ago FULL YEAR 2024 RESULTS Ateme reports FY 2024 revenues of €93.5 million, down 7% YoY. Monthly recurring revenues up 20%. EBITDA at €1.1 million. Company aims for improved profitability in 2025 Revenues EBITDA Profitability 2025 ATEME
PRESS RELEASE published on 03/19/2025 at 17:45, 1 year ago RÉSULTATS ANNUELS 2024 Ateme publie ses résultats financiers annuels 2024 : CA de 93,5 M€, MRR en hausse de 20% sur un an, EBITDA de 1,1 M€, trésorerie à 9,5 M€. Perspectives de croissance à horizon 2027 Résultats Financiers Croissance EBITDA Trésorerie ATEME
BRIEF published on 01/30/2025 at 17:50, 1 year 1 month ago Ateme Reports Stable Q4 2024 Revenues Amid Overall Decline Revenue Recurring Revenue Regional Performance Q4 2024 Profitability Goals
BRIEF published on 01/30/2025 at 17:50, 1 year 1 month ago Ateme annonce un chiffre d'affaires stable au quatrième trimestre 2024 malgré un déclin général Revenus Récurrents Revenu Performance Régionale Objectifs De Rentabilité 4e Trimestre 2024
PRESS RELEASE published on 01/30/2025 at 17:45, 1 year 1 month ago FOURTH QUARTER AND FULL YEAR 2024 REVENUES Ateme posted stable 4th quarter revenues of €30.3 million in 2024, with full-year revenues at €93.5 million, down -7% and -6% like-for-like. EBITDA expected around breakeven for 2024 Revenues Financial Results EBITDA ATEME Commercial Reorganization
PRESS RELEASE published on 01/30/2025 at 17:45, 1 year 1 month ago ACTIVITÉ DU 4ÈME TRIMESTRE ET DE L'EXERCICE 2024 Ateme réalise un CA annuel de 93,5 M€ en recul de -7%, avec une hausse de +20% du MRR et un EBITDA attendu autour de l'équilibre pour 2024 Chiffre D'affaires EBITDA Reorganisation ATEME MRR
BRIEF published on 01/27/2025 at 17:50, 1 year 1 month ago Calendrier financier 2025 d'Ateme Calendrier Financier Assemblée Générale Résultats Trimestriels Publications Financières ATEME
BRIEF published on 01/27/2025 at 17:50, 1 year 1 month ago Ateme 2025 Financial Calendar Financial Calendar General Meeting Quarterly Results ATEME Financial Publications
Published on 03/26/2026 at 13:00, 1 hour 4 minutes ago Prospect Ridge Strengthens Technical Team with Appointment of Phil Smerchanski as Senior Technical Advisor
Published on 03/26/2026 at 13:00, 1 hour 4 minutes ago GameSquare's Stream Hatchet Launches Creator Communities to Manage the Full Creator Marketing Lifecycle
Published on 03/26/2026 at 12:59, 1 hour 5 minutes ago Adcore Concludes Fiscal Year 2025 With Strong Q4 Performance
Published on 03/26/2026 at 12:45, 1 hour 19 minutes ago Quartz Mountain Reports Strong Warrant Exercise Participation and Provides Exploration Update at Maestro Project, Central British Columbia
Published on 03/26/2026 at 12:45, 1 hour 19 minutes ago Electric Royalties Provides Update on Critical Metals Royalty Portfolio
Published on 03/26/2026 at 13:47, 16 minutes ago EQS-Adhoc: Ping An Insurance (Group) Company of China, Ltd.: PROPOSED DISTRIBUTION OF FINAL DIVIDEND
Published on 03/26/2026 at 13:00, 1 hour 3 minutes ago AUDITED RESULTS FOR THE YEAR ENDED 31 DECEMBER 2025
Published on 03/26/2026 at 13:00, 1 hour 4 minutes ago Nebius AI Cloud 3.5 introduces serverless AI to give developers frictionless compute for real-world AI
Published on 03/26/2026 at 12:45, 1 hour 18 minutes ago Original-Research: CLINUVEL Pharmaceuticals Limited (von Parmantier & Cie. GmbH): Buy
Published on 03/26/2026 at 12:20, 1 hour 43 minutes ago North Peak Closes Second and Final Tranche of Previously Announced Non-Brokered Private Placement, Raising Total Funds of $5.675 Million
Published on 03/26/2026 at 07:30, 6 hours 34 minutes ago BIOPHYTIS-LYNXKITE ALLIANCE INVITED TO NVIDIA CONFERENCE: UNLEASHING AI TO REVOLUTIONIZE LONGEVITY
Published on 03/26/2026 at 07:30, 6 hours 34 minutes ago BIOPHYTIS ET LYNXKITE INVITÉS À LA CONFÉRENCE NVIDIA : L’IA AU SERVICE DE LA LONGÉVITÉ
Published on 03/25/2026 at 18:53, 19 hours 10 minutes ago CIS - Transfert Contrat de Liquidité Portzamparc - 25.03.2026
